Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

CVS to close 22 stores amid profit jump

CVS Health is closing nearly two dozen stores that are underperforming, the company announced in its third quarter earnings released Nov. 6. The store closings also coincide with a 10% jump in profit for the quarter for CVS, of $1.52 billion.

Thumbnail

How some radiologists are going the extra mile to learn about AI

Radiologists are in a position to demonstrate their value and lead the implementation of AI in healthcare—but keeping up with these evolving technologies is easier said than done.

Thumbnail

Walgreens in talks to go private

Walgreens Boots Alliance is reportedly in talks to take the company private, according to CNBC. The deal would be the largest leveraged buyout in history, and the news comes after Walgreens announced it was closing 160 in-store clinics it owns and operates.

Thumbnail

CMS finalizes 2020 payment rules

CMS has finalized payment rules for 2020, dropping a controversial coding change in the Physician Fee Schedule and a proposal to force hospitals to publicly disclose their standard pricing.

Thumbnail

Chinese-linked scientists steal US biomedical research

Other countries are targeting and stealing confidential scientific research from U.S. institutions and academic centers, according to a report from The New York Times.

Thumbnail

Highest paying physician specialties 2019

Neurosurgery is the medical specialty with the highest average annual compensation, according to the 2019 Physician Compensation Report from Doximity, which draws on responses from nearly 90,000 licensed U.S. doctors over six years.

Thumbnail

Trump administration finalizes kidney care rules

CMS has finalized changes to Medicare payment methodologies that aim to improve care for kidney care patients.

Thumbnail

Private equity has a role in increasing healthcare prices

The healthcare space has seen an influx of investment from private equity groups looking to innovate the market, but the role of these investors could also be pushing healthcare prices higher.

Around the web

The FTC alleges that pharmacy benefit managers have set up a system where they get rich, while patients are forced to pay rising insulin costs. The agency also called out drug manufacturers such as Eli Lilly, Sanofi and Novo Nordisk, saying their own actions have raised serious concerns.

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

Trimed Popup
Trimed Popup